Impact of Sequencing Targeted Therapies with High-Dose Interleukin-2 Immunotherapy

Filed under "Press Releases"
More articles »


Impact of Sequencing Targeted Therapies with High-Dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients with Metastatic Renal Cell Carcinoma from an On-going Observational IL-2 Clinical Trial: PROCLAIM

"manuscript in publication"

 



Leave Your Comments

We welcome your comments. Please leave your ideas and opinions below.




Will not be displayed on the site


Example: http://www.yoursite.com/